HomeInsightsEPS

Beta Drugs Ltd EPS

Beta Drugs Ltd EPS

stocks purchased

₹ 1.2 Cr

Volume Transacted

()

stocks purchased

5.8 K

Stocks Traded

()

Last Updated on: Nov 23, 2024

Image

Beta Drugs Ltd

NSE: BETA

EPS

₹ 37.9

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Beta Drugs Ltd is ₹ 37.9 as of 22 Nov 24 .

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242084.9
21 Nov 20241983
19 Nov 20242015
18 Nov 20242002.8
14 Nov 20242046.8
13 Nov 20242014.7
12 Nov 20242070.8
11 Nov 20242178.4
08 Nov 20242194
07 Nov 20242160.15

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Market Cap of Beta Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 202414:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 202413:59

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

02 Sep 202417:17

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Pow...

Read more

07 May 202412:58

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023...

Read more

01 Nov 202316:05

News

Beta Drugs AGM scheduled

Beta Drugs announced that the 18th Annual General Meeting (AGM) of the company will be hel...

Read more

05 Sep 202315:24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Beta Drugs Ltd

What is the EPS of Beta Drugs Ltd stock?

The Earnings Per Share (EPS) of Beta Drugs Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Beta Drugs Ltd EPS calculated?

The EPS of Beta Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Beta Drugs Ltd report its EPS?

Beta Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Beta Drugs Ltd EPS?

Factors that influence the EPS of Beta Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Beta Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Beta Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*